Clients – ranging from startups to multinational public companies, in a broad range of industries – look to Anne for her skillful ability to advise on issues related to corporate and employment law, including executive compensation, employee benefits, securities law, and corporate governance.

Anne is also a key member of the firm’s multidisciplinary ESG practice, helping corporate boards, companies, and their investors navigate a broad range of environmental, social, and governance considerations. She is also a member of the firm’s FinTech, Blockchain, and Digital Assets practice, where she regularly advises on compensation and benefits programs involving cryptocurrency and digital assets.

Part of Anne’s practice involves helping clients create, implement and administer equity and executive compensation arrangements and programs, including equity plans, phantom equity arrangements, incentive plans, deferred compensation plans, change-in-control arrangements, and severance and employment agreements. She also advises with respect to tax, corporate and securities law concerns that arise in connection with such plans and arrangements. She advises and represents a broad range of public and private companies, boards of directors and compensation committees in these matters. She also assists executives with negotiation of their compensation packages, and works closely with senior executives and founders to implement 10b5-1 plans and complex diversification strategies. Additionally, Anne has played a significant role in many public offerings, SPAC transactions and merger and acquisition transactions, representing companies in connection with complex employee benefits and compensation-related aspects.

On the corporate side of her practice, Anne leverages her broad-ranging experience to counsel clients on the intricacies of the federal securities laws. Anne advises public companies and registrants in preparing required disclosure filings and shareholder materials, and helps companies develop ESG strategies, consider disclosure requirements of director and executive compensation, understand cybersecurity issues, and address institutional investors and proxy advisory firm considerations.

In addition, Anne assists companies in implementing and administering a range of policies to address governance obligations, including insider trading, anti-hedging and claw back policies. She also provides guidance on securities laws requirements to clients involved in public and private M&A and private equity and leveraged buyout transactions, as well as debt and equity financings, divestitures, spinoffs, and IPOs.

SEC Adopts Pay Versus Performance Compensation Disclosure Requirements

September 26, 2022 | Advisory | By Xandy Walsh, Anne Bruno, Daniel T. Kajunski

Read about the SEC’s recently adopted rules to require reporting companies to disclose the so-called Pay Versus Performance relationship between a company’s financial performance and executive compensation that was “actually paid” by the company over a five-year period.

June 29, 2022 | Webinar | By Anne Bruno, Michelle Capezza, David Lagasse

Interest in cryptocurrency investments has been increasing at a rapid pace and employers don't want to be left behind. In this webinar, team members from Mintz’s Employee Benefits & Executive Compensation Practice break down key considerations employers face towards designing compensation programs to pay employees in the form of cryptocurrencies.

March 17, 2022 | Blog

In recently issued Compliance Assistance Release No. 2022-01 (the “Release”), the Department of Labor addressed cryptocurrencies as 401(k) plan investments. To the surprise of some and the delight of others, the Department did not shut the door on these investments. It did, however, counsel extreme caution.

February 9, 2022 | Webinar | By Michelle Capezza, David Lagasse, Anne Bruno

In this webinar, members from our Employee Benefits & Executive Compensation Practice discuss the latest in how employers must continue to manage their benefits and compensation programs to attract and retain talent. Hear our attorneys talk about 2022 trends in benefits and compensation and how companies should address the wide array of compliance issues affecting their programs.

January 18, 2022 | Advisory | By Megan Gates, John Condon, Anne Bruno, Melanie Ruthrauff Levy, Daniel T. Kajunski, Cynthia Larose, Breton Leone-Quick, Page R. Hubben

Read about key regulatory and other developments, including board diversity and other ESG matters, which public companies need to consider as they prepare for their fiscal year-end SEC filings and 2022 annual shareholder meetings.

July 12, 2021 | Advisory | By Anne Bruno

This advisory provides some background on Governor Baker’s COVID executive order, issued in March 2020, and outlines what its expiration will mean for Massachusetts public companies planning shareholder meetings.

January 21, 2021 | Advisory | By Megan Gates, John Condon, Daniel T. Kajunski, Anne Bruno

Read about regulatory and other developments public companies need to consider as they prepare for fiscal year-end Securities and Exchange Commission filings and 2021 annual shareholder meetings.

January 13, 2021 | Blog | By Anne Bruno

Read the transcript of CompensationStandard.com’s November 2020 webcast titled, “Pay Equity: What Compensation Committees Need to Know” in which Anne L. Bruno was among the experts to discuss pay equity, shareholder expectations, disclosure trends, board oversight, and more.

January 12, 2021 | Advisory | By Anne Bruno

This advisory discusses the SEC’s final rules — effective November 2, 2020 — governing voting advice provided by proxy advisory firms such as Institutional Shareholders Service (ISS) and Glass Lewis.

July 21, 2020 | Advisory | By Anne Bruno

This advisory discusses the SEC’s recent guidance on operations, liquidity, and capital resources disclosure that companies should consider in light of the COVID-19 pandemic.

Read less

Mintz Promotes Nine to Member

December 15, 2021

Mintz Advises JMP Group in Sale to Citizens Financial Group

November 16, 2021

Mintz Advises Cardurion Pharmaceuticals in Investment of up to $300 Million from Bain Capital

November 02, 2021

Mintz advised Cardurion Pharmaceuticals, Inc., a biotechnology company developing novel therapeutics to treat heart failure and other cardiovascular diseases, in a private investment of up to $300 million from Bain Capital Life Sciences and Bain Capital Private Equity that will enable the Boston-based company to expand its drug discovery programs.

XL Fleet Completes Merger with Pivotal Investment Corporation II, a Special Purpose Acquisition Company, Begins Trading on NYSE

December 23, 2020

‘Too Old’ to Be CEO — Bias Charges in Succession Plan

November 6, 2020

In Agenda, a Financial Times publication, Mintz Special Counsel Anne Bruno was quoted on company succession planning and how boards can effectively communicate the process and decision to candidates.